ROI may vary based on factors such as company size, employee health profiles, and current healthcare costs
Other higher-risk groups include patients who are currently up-titrating, those with severe nausea or vomiting, known gastroparesis, and individuals undergoing urgent abdominal or airway procedures
Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers
Moreover, ongoing research continues to explore the potential benefits of naltrexone in various populations, including those with co-occurring mental health disorders, highlighting its versatility and importance in the realm of addiction recovery
What is FDA-approved in the GLP-1 space today FDA-approved GLP-1 and incretin-pathway medications include drugs such as exenatide, liraglutide, dulaglutide, semaglutide, and tirzepatide, depending on indication and brand
Neal Kumar Dr